[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355968-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355968-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genomic-characterization-of-uterine-adenomatoid-tumors-reveals-recurrent-alterations-in-kmt5a-and-kmt2c","Genomic characterization of uterine adenomatoid tumors reveals recurrent alterations in KMT5A and KMT2C","","Uterine adenomatoid tumors (UATs) are rare benign mesothelial neoplasms with limited molecular characterization. Targeted sequencing and immunohistochemical profiling were applied to 20 pathologically confirmed UATs, and KMT5A knockdown was tested in Ishikawa endometrial carcinoma cells. Recurrent KMT5A and KMT2C alterations were found in all cases, with elevated TRAF7, γ-H2AX, CALB2 and Ki-67 linked to higher KMT5A expression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genomic-characterization-of-uterine-adenomatoid-tumors-reveals-recurrent-alterations-in-kmt5a-and-kmt2c/355968/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genomic-characterization-of-uterine-adenomatoid-tumors-reveals-recurrent-alterations-in-kmt5a-and-kmt2c/355968.png","ImageObject",300,407,{"name":42,"@type":43},"Bulrr","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What molecular alterations were most consistently detected in uterine adenomatoid tumors?","Question",{"text":63,"@type":64},"Recurrent mutations in KMT5A and KMT2C were identified in all 20/20 cases, with consistent co-occurrence across the cohort.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which additional genes and markers showed alteration or expression changes?",{"text":68,"@type":64},"Additional alterations were observed in HLA-B, HLA-A, ROS1, TRAF7, SDHA, and KMT2A. Immunohistochemistry showed higher expression of TRAF7, γ-H2AX, CALB2, and Ki-67 in tumors with elevated KMT5A expression.",{"name":70,"@type":61,"acceptedAnswer":71},"How did KMT5A knockdown affect cell behavior in the functional assays?",{"text":72,"@type":64},"KMT5A knockdown in Ishikawa cells reduced proliferative and migratory capacity, indicating a potential role in tumor-associated biology.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355968,1790618026,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Kang et al. Clinical Epigenetics (2026) 18:134 [https://doi.org/10.1186/s13148-026-02161-6](https://doi.org/10.1186/s13148-026-02161-6)  \nClinical Epigenetics  \nRESEARCH Open Access  \nGenomic characterization of uterine adenomatoid tumors reveals recurrent alterations in KMT5A and KMT2C  \nShufeng Kang1†, Fangfang Xu1†, Juan Tao2†, Guofang Chen3* and Shuangdi Li 1*  \nAbstract  \nBackground Uterine adenomatoid tumors (UATs) are rare benign mesothelial neoplasms with poorly characterized molecular features. Comprehensive genomic profiling of UATs remains limited.  \nMethods Targeted sequencing of 20 pathologically confirmed UATs was performed using a 641-gene panel. Immunohistochemical (IHC) analyses were conducted to assess protein expression patterns. Functional assays were performed in the Ishikawa endometrial carcinoma cell line to provide preliminary insight into the potential biological impact of KMT5A knockdown. Publicly available datasets (TCGA and cBioPortal) were analyzed to place these alterations into a broader molecular context across gynecologic malignancies.  \nResults Recurrent mutations in KMT5A and KMT2C were identified in all cases (20/20, 100%), with consistent  \nco-occurrence across the cohort. Additional alterations were observed in HLA-B (65%), HLA-A (50%), ROS1 (45%), TRAF7  \n(45%), SDHA (30%), and KMT2A (30%) . IHC analysis demonstrated higher expression of TRAF7, γ-H2AX, CALB2, and Ki-67 in tumors with elevated KMT5A expression. KMT5A knockdown in Ishikawa cells reduced proliferative and migratory capacity. Comparative analyses indicated that KMT5A mutations are uncommon in gynecologic malignancies (\u003C 3%), whereas KMT2C alterations are more broadly distributed.  \nConclusions UATs exhibit a distinctive mutational profile characterized by recurrent KMT5A and KMT2C co-mutations. These findings provide a comprehensive molecular characterization of UATs and suggest that recurrent alterations in chromatin-regulatory genes may represent characteristic genomic features that warrant further investigation. Keywords UATs, KMT5A, KMT2C, Mesothelial neoplasm, Epigenetic regulation  \n†Shufeng Kang, Fangfang Xu and Juan Tao have contributed equally to this work.  \n*Correspondence:  \nGuofang Chen[chenguofang@tongji.edu.cn](chenguofang@tongji.edu.cn)[ ](chenguofang@tongji.edu.cn)Shuangdi Li[lishuangdi@tongji.edu.cn](lishuangdi@tongji.edu.cn)  \n1Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Department  \nof Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China  \n2Department of Ophthalmology, School of Medicine, Shanghai Tenth People’s Hospital of Tongji University, Tongji University, Shanghai 200092, China  \n3Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission ","cbCaimZneaQXqDGe","https://ap.wps.com/l/cbCaimZneaQXqDGe","pdf",9939107,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Clinical and histological context of UATs\n## Molecular findings and knowledge gaps\n## Rationale for genomic characterization","[{\"question\":\"What molecular alterations were most consistently detected in uterine adenomatoid tumors?\",\"answer\":\"Recurrent mutations in KMT5A and KMT2C were identified in all 20/20 cases, with consistent co-occurrence across the cohort.\"},{\"question\":\"Which additional genes and markers showed alteration or expression changes?\",\"answer\":\"Additional alterations were observed in HLA-B, HLA-A, ROS1, TRAF7, SDHA, and KMT2A. Immunohistochemistry showed higher expression of TRAF7, γ-H2AX, CALB2, and Ki-67 in tumors with elevated KMT5A expression.\"},{\"question\":\"How did KMT5A knockdown affect cell behavior in the functional assays?\",\"answer\":\"KMT5A knockdown in Ishikawa cells reduced proliferative and migratory capacity, indicating a potential role in tumor-associated biology.\"}]","Genomic characterization of uterine adenomatoid tumors reveals recurrent alterations in KMT5A and KMT2C | PDF",1790122021,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4827362eb4a5f29ea879ac7ce4bff568.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e81b8a3c312ebf83818ab9492a96ea7d.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40445eac54905e273fc62d908ca05135.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3612f3b9268f6c8236ea24c4b0edad9f.webp",980,1306]